Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational modifications, and aggregation state shape antibody specificity, thereby guiding ...

Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving polycystic kidney disease. Early mouse studies suggest it may halt or even ...

Image of antibodies created from scratch. (UW Institute for Protein Design / Ian C. Haydon Graphic) Researchers from Nobel Laureate David Baker’s lab and the University of Washington’s Institute for ...

Specific antibody deficiency (SAD) is an immune system disorder. It occurs when you have normal levels of antibodies but an insufficient immune response to certain types of bacteria. Antibodies, also ...

An international research team led by the University of Cologne has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly ...

Some people vaccinated against COVID-19 initially acquire strong levels of neutralizing antibodies but then experience rapid declines. Measuring immunoglobulin A antibody titers post-vaccination could ...

ADCs integrate monoclonal antibodies with cytotoxic payloads, offering new treatment options for NSCLC, including biomarker-selected and biomarker-agnostic patients. ADCs are composed of an antibody, ...

The oPool + display platform combines technologies to make and test large numbers of antibodies at once. Antibodies are the critical targeting agents of the immune system and the crux of immune ...

Ever since Biogen and Eisai’s Aduhelm (aducanemab) was approved in 2021 as the first antibody to treat Alzheimer’s disease by clearing amyloid plaques from the brain, the modality has been dogged by a ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR antibodies), ...